Skip Navigation

COVID-19 Update

Due to interest in the COVID-19 vaccines, we are experiencing an extremely high call volume. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this website. Our vaccine supply remains limited. Read all COVID-19 Vaccine Information.

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

Kenneth Jay Cohen, M.B.A., M.D.

Headshot of Kenneth Jay Cohen
  • Clinical Director Pediatric Oncology
  • Professor of Oncology
Male

Expertise

Pediatric Brain Cancer, Pediatric Brain Tumors, Pediatric Neuro-Oncology, Pediatric Oncology, Pediatric Spinal Cord Tumors ...read more

Research Interests

Early-phase drug development for high-risk pediatric brain tumors ...read more

Request an Appointment

Insurance Information

Maryland Phone

410-955-8751

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital (Main Entrance)

Appointment Phone: 410-955-8751
1800 Orleans St.
The Charlotte R. Bloomberg Children's Center Building, 11th Floor
Baltimore, MD 21287 map
Fax: 410-955-0028

Background

Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse, NY. He did his general Pediatric Residency and Chief Residency at the University of Colorado, and completed his Pediatric Hematology/Oncology Fellowship at Johns Hopkins. He has served on the faculty since 1994. Dr. Cohen is co-chair of the High-Grade Glioma committee for the Children's Oncology Group and in that capacity has a particular research interest in the development of therapeutics for the treatment of infiltrating gliomas.  He serves on the scientific advisory board for a number of organizations including St. Baldricks and the Childhood Brain Tumor Foundation.

The Pediatric Neuro-Oncology program conducts a broad range of research centered primarily around the development and testing of novel therapeutics for children with brain tumors. The multidisciplinary nature of this work translates into continual collaboration with specialists in pediatric neurosurgery, radiation oncology, neuropathology, neuroradiology, neurology, neuro-ophthalmology, neuropsychology, and other related disciplines. 

...read more

Titles

  • Clinical Director Pediatric Oncology
  • Director, Pediatric Neuro-Oncology
  • Director, Strategic Planning, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Professor of Oncology
  • Professor of Pediatrics

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD; SUNY Upstate Medical University (1987)

Research & Publications

Research Summary

More children die of brain tumors than of any other type of pediatric cancer. Significant advances have been made in surgical and supportive care, but with fewer evident therapeutic benefits. A variety of new therapies are being studied in the hope of finding new treatments that are more effective, yet less toxic to the developing brain. One promising new avenue is research that links neuropathology with neurosurgical sciences.

Clinical Trial Keywords

Pediatric brain tumors, Neuro-Oncology

Selected Publications

Cohen KJ, Pollack IF, Zhou T, Buxton A, Holmes EJ, Burger PC, Brat DJ, Rosenblum MK, Hamilton RL, Lavey RS, Heideman RL. Temozolomide in the treatment of high-grade gliomas in children; a report from the Children’s Oncology Group.  Neuro Oncol. 2011 Mar;13(3):317-23

Cohen KJ, Heideman RL, Zhou T, Holmes EJ, Lavey RS, Bouffet E, Pollack IF.  Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas:  A report from the Children’s Oncology Group.  Neuro Oncol. 2011 Apr;13(4):410-6

Cohen KJ, Gibbs IC, Fisher PG, Hayashi RJ, Macy ME, Gore L. A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood. Neuro Oncol. 2013 Mar 3.

Wolf DS, Cohen KJ.  Is low and slow the way to go?  Metronomic therapy in the treatment of pediatric brain tumors.  CNS Oncol. 2013 May;2(3):211-3.

Martin AM, Raabe E, Eberhart C, Cohen KJ.  Management of pediatric and adult patients with medulloblastoma.  Curr Treat Options Oncol. 2014 Dec;15(4);581-94

Activities & Honors

Memberships

  • American Society of Clinical Oncology, 1994
  • American Society of Pediatric Hematology/Oncology, 1997
  • Society for Neuro-Oncology, 1999

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button